These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11939646)

  • 1. Drugs used to limit blood surface interactions.
    Hilt T; Bayat M
    Crit Care Nurs Clin North Am; 2002 Mar; 14(1):7-16. PubMed ID: 11939646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond heparin and warfarin: the new generation of anticoagulants.
    Weitz JI; Linkins LA
    Expert Opin Investig Drugs; 2007 Mar; 16(3):271-82. PubMed ID: 17302522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ten most commonly asked questions about stroke prevention in atrial fibrillation.
    Halperin JL
    Cardiol Rev; 2001; 9(4):187-92. PubMed ID: 11464805
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin versus aspirin for stroke prevention (BAFTA).
    Diug B; Lowthian J; Evans S
    Lancet; 2007 Nov; 370(9599):1606; author reply 1606-7. PubMed ID: 17993355
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological interactions between ditazole and anticoagulant drugs.
    Caprino L; Falchetti R; Borrelli F
    Arzneimittelforschung; 1975; 25(12):1920-3. PubMed ID: 56180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of homeostasis in coagulation during cardiopulmonary bypass.
    Spiess BD
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):2-5; discussion 36-7. PubMed ID: 10468242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anticoagulants.
    Linkins LA; Weitz JI
    Semin Thromb Hemost; 2003 Dec; 29(6):619-31. PubMed ID: 14719178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolism.
    Haas S
    Drugs; 2004; 64 Suppl 1():7-16. PubMed ID: 15586623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
    Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
    Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of plasmatic coagulation: what is new?].
    Schwarz M; Bode C
    Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and anticoagulation.
    Maxim R
    Med Health R I; 2001 Dec; 84(12):410-1. PubMed ID: 11797587
    [No Abstract]   [Full Text] [Related]  

  • 14. [Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation. Results of the BAFTA trial].
    Liakishev AA
    Kardiologiia; 2008; 48(2):68. PubMed ID: 18261012
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of oral anticoagulant therapy.
    Dittus C; Ansell J
    Prim Care; 2013 Mar; 40(1):109-34. PubMed ID: 23402464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe sepsis.
    Bernard G
    Am J Surg; 2002 Dec; 184(6A Suppl):S3-4. PubMed ID: 12521611
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight watching in cardiology: low molecular weight heparin for acute coronary syndromes.
    Levi M; Peters RJ; Büller HR
    Cardiovasc Res; 1998 Mar; 37(3):564-6. PubMed ID: 9659439
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy or low-dose heparin and neuraxial anaesthesia.
    Schneider MC; Caliezi C; Seeberger MD
    Acta Anaesthesiol Scand Suppl; 1997; 111():219-21. PubMed ID: 9421021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.